Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: Frameshift peptides for treating MSI+ blood cancers - Maletzki, Claudia; Schmidt, Fabian; Dirks, Wilhelm G.; Schmitt, Michael; Linnebacher, Michael (European journal of cancer, 2013)
Gesehen am 17.06.2021